IN2009CN03566A - - Google Patents

Download PDF

Info

Publication number
IN2009CN03566A
IN2009CN03566A IN3566CHN2009A IN2009CN03566A IN 2009CN03566 A IN2009CN03566 A IN 2009CN03566A IN 3566CHN2009 A IN3566CHN2009 A IN 3566CHN2009A IN 2009CN03566 A IN2009CN03566 A IN 2009CN03566A
Authority
IN
India
Prior art keywords
compounds
methods
preparing
relates
bompositions
Prior art date
Application number
Inventor
Josephus H M Lange
Cornelis G Kruse
Belal Shadid
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Priority claimed from PCT/EP2007/064169 external-priority patent/WO2008074816A1/en
Publication of IN2009CN03566A publication Critical patent/IN2009CN03566A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Abstract This invention concerns compounds with a combination of cannabinoid-CBi antagonism and cholinesterase inhibition, to pharmaceutical compositions containing these compounds, to methods for preparing the compounds, methods for preparing novel intermediates useful for their synthesis, and methods for preparing compositions. The invention also relates to the uses of such compounds and bompositions, particularly for treating Alzheimer's disease, cognitive disorders, memory disorders, dementia, attention deficits, traumatic brain injury, drug dependence, addiction and substance abuse. In particular the invention relates to compounds of the general formula (1) wherein the symbols have the meanings given in the specification.
IN3566CHN2009 2006-12-20 2007-12-19 IN2009CN03566A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06126584 2006-12-20
PCT/EP2007/064169 WO2008074816A1 (en) 2006-12-20 2007-12-19 Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition

Publications (1)

Publication Number Publication Date
IN2009CN03566A true IN2009CN03566A (en) 2015-08-07

Family

ID=38024247

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3566CHN2009 IN2009CN03566A (en) 2006-12-20 2007-12-19

Country Status (7)

Country Link
CN (1) CN101848907A (en)
AR (1) AR064379A1 (en)
BR (1) BRPI0721060A2 (en)
IN (1) IN2009CN03566A (en)
MX (1) MX2009006889A (en)
TW (1) TW200843772A (en)
ZA (1) ZA200903779B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023534496A (en) * 2020-07-14 2023-08-09 リスキュア バイオサイエンシズ カンパニー，リミテッド COMPOSITION FOR TREATMENT OF BRAIN DISEASES CONTAINING PEDIOCOCCUS INOPINATAS OR EXTRACELLULAR EROSIDE DERIVED THEREOF AS AN ACTIVE INGREDIENT
CN113880899B (en) * 2020-10-30 2023-06-23 杭州拉林智能科技有限公司 Flavonoid glycoside-organic amine nerve agonist double salt compound as well as preparation method and application thereof

Also Published As

Publication number Publication date
TW200843772A (en) 2008-11-16
MX2009006889A (en) 2009-07-07
BRPI0721060A2 (en) 2014-02-25
ZA200903779B (en) 2010-04-28
CN101848907A (en) 2010-09-29
AR064379A1 (en) 2009-04-01

Similar Documents

Publication Publication Date Title
IL198926A0 (en) Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition
TW200633957A (en) Compounds
UA94660C2 (en) Amino-heterocyclic compounds
JO3146B1 (en) Novel Heterocyclic Derivatives and Their Use in the Treatment of Neurological Disorders
RS20060129A (en) /1,8/naphthyridin-2-ones and related compounds for the treatment of schizophrenia
MXPA06011194A (en) Thiadiazolidinones as gsk-3 inhibitors.
TW200531689A (en) Therapeutic agents
ATE455763T1 (en) PIPERIDINE AND RELATED COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
TW200602297A (en) Sulfonamide compounds for the treatment of neurodegenerative disorders
UA100232C2 (en) Crystalline forms glyt1
TW200633956A (en) Compounds
MX2009005509A (en) 2-aminoquinolines as 5-ht(5a) receptor antagonists.
TW200734324A (en) Therapeutic agents
TW200714282A (en) Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
DE602005021698D1 (en) OXYGENIC HETEROCYCLES AS GLYCINTRANSPORTERINHIBIEREN COMPOUNDS
PL1745010T3 (en) Substituted cyclohexyl-1,4-diamine derivatives
WO2005095348A3 (en) Pyrazole-amine compounds for the treatment of neurodegenerative disorders
MX2009007405A (en) Compounds with a combination of cannabinoid-cb1 antagonism and serotonin reuptake inhibition.
IN2009CN03566A (en)
WO2008092877A3 (en) 8-oxa-1, 4-diazaspiro [4,5] dec-3-en-1-yl and 1,4, 8-triazaspiro [4,5] dec- 3-en-1-yl acetamides as glyti transporter inhibitors in treatment of neurological and neuropsychiatric disorders
RS20080139A (en) Imidazole coumpounds for the treatment of neurological disorders
WO2008102888A1 (en) Novel pseudoglycolipid and use thereof
EP2063710A4 (en) Difluorinated piperidines for treatment of alzheimer's disease and related conditions
MX2010008239A (en) 2-aminoquinolines.
IL188115A0 (en) 8-alkoxy-4-methyl-3,4-dihdro-quinazolin-2-